Dissecting cancer heterogeneity--an unsupervised classification approach
- PMID: 24004832
- DOI: 10.1016/j.biocel.2013.08.014
Dissecting cancer heterogeneity--an unsupervised classification approach
Abstract
Gene-expression-based classification studies have changed the way cancer is traditionally perceived. It is becoming increasingly clear that many cancer types are in fact not single diseases but rather consist of multiple molecular distinct subtypes. In this review, we discuss unsupervised classification studies of common malignancies during the recent years. We found that the bioinformatic workflow of many of these studies follows a common main stream, although different statistical tools may be preferred from case to case. Here we summarize the employed methods, with a special focus on consensus clustering and classification. For each critical step of the bioinformatic analysis, we explain the biological relevance and implications of the technical principles. We think that a better understanding of these ever more frequently used methods to study cancer heterogeneity by the biomedical community is relevant as these type of studies will have an important impact on patient stratification and cancer subtype-specific drug development in the future.
Keywords: Cancer subtypes; Consensus clustering; Gene expression; Personalized medicine; Stratified medicine.
Crown Copyright © 2013. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines.PLoS One. 2018 Sep 14;13(9):e0203824. doi: 10.1371/journal.pone.0203824. eCollection 2018. PLoS One. 2018. PMID: 30216380 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Multi-class clustering of cancer subtypes through SVM based ensemble of pareto-optimal solutions for gene marker identification.PLoS One. 2010 Nov 12;5(11):e13803. doi: 10.1371/journal.pone.0013803. PLoS One. 2010. PMID: 21103052 Free PMC article.
-
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.Genome Med. 2021 Sep 1;13(1):143. doi: 10.1186/s13073-021-00956-1. Genome Med. 2021. PMID: 34470666 Free PMC article.
-
Cancer classification in the genomic era: five contemporary problems.Hum Genomics. 2015 Oct 19;9:27. doi: 10.1186/s40246-015-0049-8. Hum Genomics. 2015. PMID: 26481255 Free PMC article. Review.
Cited by
-
Breast cancer subtype predictors revisited: from consensus to concordance?BMC Med Genomics. 2016 Jun 3;9(1):26. doi: 10.1186/s12920-016-0185-6. BMC Med Genomics. 2016. PMID: 27259591 Free PMC article.
-
A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer.Oncotarget. 2014 Aug 15;5(15):6437-52. doi: 10.18632/oncotarget.2237. Oncotarget. 2014. PMID: 25115384 Free PMC article.
-
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.Oncogene. 2016 Nov 17;35(46):6026-6037. doi: 10.1038/onc.2016.134. Epub 2016 May 9. Oncogene. 2016. PMID: 27157610 Free PMC article.
-
Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges.Cancer Med. 2024 Jul;13(14):e70041. doi: 10.1002/cam4.70041. Cancer Med. 2024. PMID: 39054866 Free PMC article. Review.
-
Next-Generation Molecular Discovery: From Bottom-Up In Vivo and In Vitro Approaches to In Silico Top-Down Approaches for Therapeutics Neogenesis.Life (Basel). 2022 Mar 2;12(3):363. doi: 10.3390/life12030363. Life (Basel). 2022. PMID: 35330114 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources